不同浓度CCl4注射联合饮用乙醇诱导大鼠肝硬化模型研究

doi:10.3969/j.issn.1672-5069.2016.06.018

Abstract

Zhai Wei, Diao Guanghao,Li Ruisheng, et al.. Alcohol and CCl4-induced liver cirrhosis in rats[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 713-714.

[1] 李小杉，肖静，高月霞. 原发性肝癌患者生存质量研究新进展.实用肝脏病杂志2011，14（3） :236-238.
[2] 顾永珍.原发性肝癌的手术治疗与临床分析.吉林医学，2011，32（3）: 535-536.
[3] 欧阳兵，吴威，徐政光.肝硬化合并肝癌患者出现低血糖的临床表现.当代医学，2010，16（28）: 45－46.
[4] 郭若涵，白彬.大型动物实验性肝纤维化及肝硬化模型的研究进展.世界华人消化杂志，2014，21（5）: 421－426．
[5] 李栋，张乐玲，侯怀水，等.四氯化碳诱导兔肝硬化模型的动态研究.世界华人消化杂志，2006，14（14）: 1403-1407.
[6] Chatterjee S，Vrolix G，Depoortere I，et al．The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis．BMC Infect Dis，2005，2（5）: 45-46.
[7] Kang JS，Wanibuchi H，Morimura K， et al． Enhancement by estradiol 3－benzoate in thioacetamide-induced liver cirrhosis of rats．Toxicol Sci，2005，85（1） : 720－726.
[8] Sakaida I，Hironaka K，Terai S，et al．Gadolinium chloride reverses dimethylnitrosamine （DMN）-induced rat liver fibrosis with increased matrix metalloproteinases （MMPs） of Kupffer cells．Life Sci，2003，72（8）: 943－959.
[9] Brnd L，Hadrup N，Salling N，et al．Uncoupling of vasopressin signaling in collecting ducts from rats with CBL－induced liver cirrhosis．Am J Physiol Renal Physiol，2004，287（4）: F806－F815.
[10] Li J，Niu JZ，Wang JF，et al．Pathological mechanisms of alcohol-induced hepatic portal hypertension in early stage fibrosis rat model．World J Gastroenterol，2005，11（41）: 6483－6488.
[11] Cutrin C，Menino MJ， Perez-Becorra E，et al. Lactacidaemia and perivenular fibrosis in an experimental model of cirrhosis in rats given carbon tetrachloride and ethanol. Med Sci Res，2014，20（8）:587-588.
[12] Chatamra K， Proctor E. Phenobarbitone-inducded enlargement of the liverin the rat: its relationship to carbon tetracholride–induced cirrhosis.Br J Exp Path，2013，62（5）: 283-288.
[13] Chae HB， Jang LC， Park SM， et al. An experimental model of hepatic fibrosis induced by alcohol and CCl4:can the lipopolysaccharide prevent liver injury induced by alcohol and CCl4. Taehan Kan Hakhoe Chi， 2013， 8（2）:173-178.

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Ren Yufei, Chen Xiaoqing, Kong Weizong, et al.. Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro [J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
[4]	Xu Fei, Li Weirong.. Protective effects of astragaloside in rats with CCL₄-induced liver injuries [J]. Journal of Practical Hepatology, 2019, 22(6): 808-811.
[5]	Gao Lei, Cao Lei, Wang Ruifang, et al.. Protective effect of human umbilical cord mesenchymal stem cell transplantation on alcoholic liver injury in rats [J]. Journal of Practical Hepatology, 2019, 22(6): 812-815.
[6]	Li Yingyi, Guo Cuifen, Zhang Ruinan, et al.. Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
[7]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[8]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[9]	Zhu Yage, Liu Jinfeng.. Therapeutic efficacy of adenosine methionine and glycyrrhizin combination in treatment of patients with alcoholic cirrhosis and its effect on serum BGP levels [J]. Journal of Practical Hepatology, 2019, 22(6): 872-875.
[10]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[11]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[12]	Lin Qiuxiang, Wang Xuewen, Huang Zuxiong, et al. Protective effects of breviscapine on liver and intestinal mucosal barrier functions in rats with hepatic ischemia-reperfusion injury [J]. Journal of Practical Hepatology, 2019, 22(5): 636-639.
[13]	Shi Xiaolong, Du Rui, Qin Geping, et al. Protective effect of sevoflurane on sepsis-induced liver injury in rats [J]. Journal of Practical Hepatology, 2019, 22(5): 640-643.
[14]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[15]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.

Alcohol and CCl4-induced liver cirrhosis in rats

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments